NEW YORK, July 6 (Reuters) - Genzyme Corp. said on Friday its experimental drug for diarrhea linked to a severe bacteria failed to meet the main goal of a late-stage study. Genzyme's tolevamer did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback